Stefan Kindler

Stefan Kindler is a Professor and Principal Investigator at the Institute of Human Genetics within the Center for Obstetrics and Pediatrics at the University Medical Center Hamburg-Eppendorf (UKE). His research focuses on the genetic basis of neurodevelopmental disorders and molecular mechanisms underlying neurological conditions.

Dr. Kindler's research spans multiple areas of genetics and neuroscience, with particular emphasis on:

• Genetic variants associated with neurodevelopmental disorders
• Molecular mechanisms of synaptic function and dysfunction
• RNA biology and its role in neurological development
• Genetic etiology of cognitive impairment and autism spectrum disorders
• Mechanisms of channelopathies in neurological conditions

Analysis of Dr. Kindler's recent publications (2012-2024) reveals a consistent research trajectory focused on identifying genetic causes of neurodevelopmental disorders and understanding their molecular mechanisms. His work frequently involves international collaborations and spans from basic molecular neuroscience to clinical genetics. A significant portion of his research investigates ion channel variants (particularly KCND1, KCND2) and their role in neurological conditions, as well as the molecular basis of synaptic protein function in disorders like autism. His 2024 publication on KCND1 variants in X-linked neurodevelopmental disorders represents the latest advancement in this line of research.

Dr. Kindler has contributed to numerous significant publications in high-impact journals including Nature Communications, American Journal of Human Genetics, and Journal of Neuroscience. Some notable contributions include:

• Identification of KCND1 variants in X-linked neurodevelopmental disorders (2024)
• Discovery of dominant KPNA3 mutations causing hereditary spastic paraplegia (2021)
• Elucidation of how AGO2 mutations impair RNA interference and neurological development (2020)
• Investigation of SAPAP4-deficient mice as a model for cognitive impairment (2019)

As a principal investigator at the Institute of Human Genetics, Dr. Kindler leads research efforts connecting molecular genetics with clinical neurology. His laboratory appears to focus on both basic research of synaptic proteins and RNA mechanisms, as well as translational research connecting genetic findings to clinical phenotypes. His work often involves collaboration with international research groups and clinical centers across Europe, as evidenced by the multi-national author lists on his publications.